Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Another Quebec-based furniture company to shut down operations due to U.S. tariffs

May 1, 2026

Quebec says it will table domestic violence prevention law modelled after Clare’s law

May 1, 2026

Liberals want committees to be ‘open,’ minister says as Tories cry foul

May 1, 2026

Court restricts U.S. abortion access, blocks mailing of mifepristone pill

May 1, 2026

Microsoft tests redesigned Windows 11 Run menu with dark mode and more

May 1, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » METHODE ELECTRONICS, INC. CLASS ACTION: MEI Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit
Press Release

METHODE ELECTRONICS, INC. CLASS ACTION: MEI Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit

By News RoomSeptember 17, 20244 Mins Read
METHODE ELECTRONICS, INC. CLASS ACTION: MEI Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit
Share
Facebook Twitter LinkedIn Pinterest Email

SAN DIEGO, Sept. 17, 2024 (GLOBE NEWSWIRE) —

Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Methode Electronics, Inc. (NYSE: MEI) common stock between June 23, 2022 and March 6, 2024. Methode designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (“OEMs”).

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

The Allegations: Robbins LLP is Investigating Allegations that Methode Electronics, Inc. (MEI) Misled Investors Regarding its Business Prospects

According to the complaint, defendants’ failure to disclose adverse facts regarding problems at the Company’s Monterrey facility and efforts to transition away from the GM center console program caused Methode stock to trade at artificially inflated prices during the class period.

Specifically, plaintiff alleges: (a) that the Company had lost highly skilled and experienced employees during the COVID-19 pandemic necessary to successfully complete the Company’s transition from its historic low mix, high volume production model to a high mix, low production model at its Monterrey facility; (b) that the Company’s attempts to replace its GM center console production with more diversified, specialized products for a wider array of vehicle manufacturers and OEMS, in particular in the EV space, had been plagued by production planning deficiencies, inventory shortages, vendor and supplier problems, and, ultimately, botched execution of the Company’s strategic plans; (c) that the Company’s manufacturing systems at its critical Monterrey facility suffered from a variety of logistical defects, such as improper system coding, shipping errors, erroneous delivery times, deficient quality control systems, and failures to timely and efficiently procure necessary raw materials; (d) that the Company had fallen substantially behind on the launch of new EV programs out of its Monterrey facility, preventing the Company from timely receiving revenue from new EV program awards; and (e) that, as a result of (a)-(d) above, the Company was not on track to achieve the 2023 diluted EPS guidance or the 3-year 6% organic sales CAGR represented to investors and such estimates lacked a reasonable factual basis.

Following a series of corrective disclosures, the price of Methode stock dropped precipitously from a class period high of over $50 per share to less than $10 per share by mid-June 2024 – a decline of more than 80%, causing investors to suffer hundreds of millions of dollars in financial losses.

What Now: You may be eligible to participate in the class action against Methode Electronics, Inc. Shareholders who want to serve as lead plaintiff for the class must submit their application to the court by October 25, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against Methode Electronics, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/27b9596d-8964-43da-a117-6ba8daeddb75

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Carbonara Announces Run for U.S. Congress in Florida’s Redrawn 22nd District

HII’s Ingalls Shipbuilding Hosts “Signing Day” Celebrating Shipbuilder Academy Graduates

Fort Lauderdale Commissioner John Herbst Endorses Michael Carbonara for Congress in FL-22

Northrop Grumman Honors Top Suppliers Driving Industrial Innovation

GuardHouse Camera Analyzed: All You Need To Know About the GuardHouse Watch Eye

Bevacizumab Biosimilars Market Trastuzumab Biosimilars Market Analysis Report 2026: $2.42 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

B2BROKER Group Puts AI at the Core of B2TRADER as Technology Enters a New Era

Adalimumab, Infliximab and Etanercept Biosimilars Trastuzumab Biosimilars Research Report 2026: $8.05 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035

Whitespace Makes Iris, AI Intelligence Analysis Agent, Generally Available to Authorized DoW and IC Users

Editors Picks

Quebec says it will table domestic violence prevention law modelled after Clare’s law

May 1, 2026

Liberals want committees to be ‘open,’ minister says as Tories cry foul

May 1, 2026

Court restricts U.S. abortion access, blocks mailing of mifepristone pill

May 1, 2026

Microsoft tests redesigned Windows 11 Run menu with dark mode and more

May 1, 2026

Latest News

CSIS says violent extremism radicalization becoming more complex to counter

May 1, 2026

Apple raises the Mac Mini’s starting price

May 1, 2026

Carbonara Announces Run for U.S. Congress in Florida’s Redrawn 22nd District

May 1, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version